Gladstone NOW: The Campaign Join Us on the Journey✕
In response to the COVID-19 crisis, Gladstone scientists have pivoted their research to focus on finding better diagnostics, treatments, and preventive measures to help end this global pandemic.
Gladstone President Deepak Srivastava and Gladstone Foundation Board Chair Bill Younger sat down together to take a deeper look at the most promising COVID-19 projects at Gladstone.
Support Our COVID-19 Research Efforts
Gladstone scientists are moving quickly to respond to the coronavirus outbreak. Help us end this pandemic.
Science in Seconds | An Unprecedented Map of Human Immune Cells
Video
August 28, 2026
Science in Seconds | An Unprecedented Map of Human Immune Cells
In this video, Gladstone scientists Emma Dann and Ronghui Zhu explain how their new study offers a powerful framework for designing cancer immunotherapies and treating autoimmune conditions.
Turning the Tide on Tau: Q&A With Gladstone’s Lennart Mucke
Article
July 1, 2026
Turning the Tide on Tau: Q&A With Gladstone’s Lennart Mucke
Nearly 20 years after his landmark study uncovered novel roles of tau in Alzheimer’s disease, Gladstone's Lennart Mucke shares his perspective on new clinical data that could transform the future of brain health.
Mucke Lab Alzheimer’s Disease Gladstone Experts Neurological Disease News ReleaseThis Is AI Decoding the Genetic Cause of Disease
Video
March 23, 2026
This Is AI Decoding the Genetic Cause of Disease
In this video, Katie Pollard and Deepak Srivastava explain how Gladstone scientists are combining AI models with novel tools in the lab to finally decode the entire human genome.
Gladstone Experts Pollard Lab Srivastava Lab AI